Логин: Пароль: ?
 
Продукты питания Ткань, одежда, обувь, постельное белье, текстиль Строительные материалы Бумага, пластик, промтовары Биотопливо Продукция для сельского хозяйства, зоотовары Косметика, средства гигиены Медицинские товары и препараты, лекарства Иное

 

 

 

 

 

 

 

Новости/Аналитика

Israeli experience useful for the national hemp market

14.04.2021

About 84% of licensees are allowed to use cannabis inflorescences, compared to about 16% of patients receiving the plant's extract oil. One of the explanations for the sharp increase in the number of patients in recent months is the cheaper and easier access to the license in terms of the cost of purchasing the aforementioned herbal therapeutic agent, which is currently only 285 shekels (about $ 87).

On the pages of the specialized electronic edition of Ukrainian cannabis growers, the question of the advisability of regulating the possibility of growing therapeutic hemp not only for legal entities, but also for individuals, has been raised more than once, as well as about that. that most patients are interested in the flowers and leaves of the plant and certainly not primarily in the pharmacological preparations made on the basis of the plant. In particular, the article “ British Columbia Officials Call for a“ Reconsideration ”of the Medical Cannabis Program ” emphasizes that 43,211 licenses were issued in Canada at the end of 2020 for personal or special medical production of the cannabis plant. As this issue is in Israel, let's try to understand this material.

The number of cannabis therapeutic licenses in Israel continues to grow at a record pace and as of March 2021 stands at around 88,000 patients. According to the published data of the Ministry of Health, the total volume of use of hemp raw materials by licensees is already more than 3.1 tons of therapeutically active “green mass” of the plant per month, with the main reason for obtaining a license being “pain”, and the second reason being “other”. 

It should be noted that over 3,000 new licenses were issued during March alone, which is similar to the almost constant monthly average since summer 2020, at about 100 new patients per day. According to this growth rate, the number of licenses for the medicinal properties of cannabis in Israel will reach 100,000 in about four months.

Number of licensees using the therapeutic properties of cannabis in Israel

As of last month, there are 88,428 cannabis therapeutic licenses in Israel, up from 59,674 in March last year and 32,651 in March 2019 since the effective date for the release of therapeutically active green mass. hemp in pharmacies. That is, we can talk about an almost 3-fold increase in the number of patients in two years.

The total consumption of tens of thousands of license holders in Israel indicated in the permitting documentation reached 3.19 tonnes in March, up from 3.06 tonnes in February and 2.95 tonnes in January. It should be noted that this is an allowable amount, and not necessarily the amount actually purchased in stores.

The volume of hemp raw materials used monthly by patients

As with every month, the main reason for licensing cannabis therapeutic properties is the chronic pain clause. Of the 3000 new licensees who joined last month, about 1750 received a license with the above diagnosis, which is more than 50%. The second leading item for licensing therapeutically active cannabis green matter in March was “other”, for which more than 800 Israelis were licensed. Also, for the first time since the industry was established more than a decade ago, the diagnosis of Psychiatry surpassed the diagnosis of Oncology last month as a basis for a license to use the therapeutic properties of cannabis.

Commentary of the specialists of the Association "Ukrainian technical hemp"

In March 2021, as in previous months, about 84% of license holders are eligible to use cannabis inflorescences, compared to about 16% of patients receiving the plant's extract oil. One of the explanations for the sharp increase in the number of patients in recent months is the cheaper and easier access to the license in terms of the cost of purchasing the aforementioned herbal therapeutic agent, which is currently only 285 shekels (about $ 87).

Once again, I would like to emphasize that patients in pharmacies are definitely not primarily looking for pharmacological preparations based on the therapeutic properties of cannabis, but plant flowers. Considering the fact that in 2021 Ukraine will already be grown on an industrial scale varieties of technical hemp of a therapeutic orientation, the flowers of these plants, which have significant therapeutic properties, already from August 2021 can treat a significant number of citizens of our country who need it. There is little left - to develop a legal framework regulating the legality of this activity.

Потенциал национального рынка каннабиноидных косметических препаратов
17.01.2024

В Украине потребитель готов для выведения на рынок линейки национальной профессиональной CBD косметической продукции

Объявления
Все объявления »
 
 

facebook

telegram

twitter